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Scand J Clin Lab Invest 1990; 50: 195-198 
Different behaviour of the TV-terminal and C-terminal 
fragment of proatrial natriuretic factor in plasma of 
healthy subjects as well as of patients with cirrhosis 
A . L . G E R B E S , A . M . V O L L M A R , * G . T H I B A U L T , 1 
R . M . A R E N D T , M . C A N T I N + & G . P A U M G A R T N E R 
Departments of Medicine II and I, Klinikum Grosshadern, Institute of Pharmacology, Toxicology 
and Pharmacy, University of Munich, Munich, F R G and ^Clinical Research Institute of Montreal, 
Montreal, Quebec, Canada 
Gerbes A L , Vollmar A M , Thibault G, Arendt RM, Cantin M, Paumgartner G. 
Different behaviour of the /V-terminal and C-terminal fragment of proatrial natri-
uretic factor in plasma of healthy subjects as well as of patients with cirrhosis. 
Scand J Clin Lab Invest 1990; 50: 195-198. 
N-terminal (atrial natriuretic factor (ANF) 1-98) and C-terminal (ANF 99-126) 
fragments of proatrial natriuretic factor (NTA and CTA, respectively) were deter-
mined in plasma of healthy subjects adopting different postures and in patients 
with cirrhosis. Seven healthy subjects were investigated while seated and 30 min 
after assuming a horizontal position. NTA plasma concentrations increased in 
subjects in the horizontal position (from 7341250 (SE) fmol/ml to 902+227 
fmol/ml; p<0.05). In contrast, CTA plasma concentrations remained unchanged 
(9.2±1.3 fmol/ml vs 8.911.6 fmol/ml). In 10 patients with cirrhosis of the liver, 
NTA concentrations were markedly (p<0.001) elevated compared to 11 healthy 
subjects (23341291 fmol/ml vs 7431155 fmol/ml). However, there was no dif-
ference of CTA plasma levels between cirrhotic patients and healthy subjects 
(8.711.3 fmol/ml vs 8.210.9 fmol/ml). These data demonstrate changes of the 
plasma concentration of the N-terminal fragment of proatrial natriuretic factor by 
posture and in liver disease, in contrast to unchanged levels of the C-terminal 
fragment. 
Key words: atrial natriuretic factor (ANF); cirrhosis; posture 
A. L . Gerbes MD, Medizinische Klinik II, Klinikum Grosshadern, University of 
Munich, Marchioninistrasse 15, D-8000 München 70, Federal Republic of 
Germany 
Proatrial natriuretic factor (atrial natriuretic fac-
tor (ANF) 1—126) is stored in atrial granules, 
released and cleaved upon appropriate stimula-
tion; the C-terminal fragment, CTA (ANF 
99-126) has been identified as biologically 
active circulating peptide (for review see [1,2]). 
Recently, presence of the N-terminal fragment 
NTA (ANF 1-98) has been demonstrated in 
plasma of rat and man [3, 4] and there is 
increasing evidence for cosecretion of NTA with 
CTA [3-5]. Plasma concentrations of NTA have 
been found several-fold higher compared to 
195 
196 A.L. Gerbes ttal 
respective CTA concentrations [3-6] , probably 
owing to a longer half-life of NTA [3]. 
Therefore, an increase of pro-ANF release may 
be more sensitively detected by determining the 
^/-terminal than the C-terminal fragment in plas-
ma. To test this hypothesis, in the present study 
NTA and CTA plasma concentrations were 
determined upon a change of posture, which 
may be regarded as a subtle stimulus of pro-
A N F release. 
More pronounced elevations of NTA than of 
CTA have been observed in plasma of patients 
with chronic renal failure, suggesting a role of 
the kidney in eliminating NTA from the circu-
lation [4J. The possible role of the liver, the 
other major organ for clearance of endogenous 
compounds, in the elimination of NTA has not 
yet been addressed. Therefore, in the present 
study NTA and CTA plasma concentrations 
were determined in patients with chronic liver 
disease. 
M A T E R I A L S A N D M E T H O D S 
Subjects 
Eleven healthy subjects, aged 25 to 65 (mean 
37±4) years and 10 patients with cirrhosis of 
the liver (histologically confirmed, mostly in 
advanced stage with ascites), aged 47 to 75 
(mean 5 8 ± 3 ) years, were investigated (sitting 
position) after their informed consent had been 
obtained. The subjects showed no evidence of 
cardiovascular, renal or pulmonary disease. 
They were on a regular diet, containing approxi-
mately 150 meq sodium/day. 
Change of posture 
Seven healthy subjects, aged 20 to 65 (mean 
3 5 ± 6 ) years were investigated. Blood samples 
were taken after they had been sitting comfort-
ably on a chair for 30 min. Thereafter, they 
assumed a horizontal position, lying on a bed in 
supine position. Thirty min after this change of 
posture another blood sample was taken. Heart 
rate and blood pressure were recorded in both 
positions. 
Determination ofANF 
CTA was determined by radio-immunoassay 
(RIA) with antibody Toni III ' (no evidence of 
cross-reactivity with NTA), as described in 
detail previously [7]. The RIA procedure for 
NTA with antiserum 'GT 23' (no cross-react-
ivity with CTA detectable) has been reported in 
detail [3]. Immunoreactivity has been identified 
as CTA and NTA, respectively, by high-
performance liquid chromatography (HPLC) 
techniques [5, 7]. Plasma renin activity was 
determined as described by Wernze et al. [8]. 
Statistical evaluation 
Differences of CTA and NTA plasma concen-
trations, of plasma renin activity, heart rate and 
mean arterial pressure, induced by the change of 
posture were calculated by paired t-test. CTA 
and NTA plasma levels of healthy subjects and 
controls were compared by unpaired t-test. A 
value of p<0.05 was considered significant. 
Data are presented as mean and standard error. 
R E S U L T S 
Change of posture 
NTA concentrations in seven healthy subjects 
were about a hundred-fold higher (p<0.001) 
than the corresponding CTA concentrations 
(Table I). The change of posture to the supine 
position did not affect CTA levels, whereas 
NTA concentrations significantly increased 
(p<0.05). Mean arterial pressure did not 
change, the heart rate decreased (p<0.01) and 
plasma renin activity tended to decrease 
(p<0.08). 
ANF in patients with cirrhosis 
In sitting position, CTA concentrations in 10 
patients with cirrhosis were not different from 
those in 11 healthy subjects (8.7±1.3 fmol/ml vs 
T A B L E I. Effects of change of posture in seven healthy 
subjects 
Sifting Supine P 
C-terminal ANF 8.911.6 9.2±1.3 — 
(fmol/ml) 
/V-terminal ANF 734±250 902 ±227 <0.05 
(fmol/ml) 
Plasma renin activity 2.6±0.5 1.610.3 <0.08 
(ng AI/ml/h) 
Heart rate 69.7±3.6 61.112.1 <0.01 
(min-1) 
Mean arterial 
pressure (mmHg) 93.1 ±3.6 95.716.1 — 













C T A 
o healthy subjects 
N T A 
> patients with cirrhosis 
FIG. 1. Plasma concentrations of C-terminal (CTA) 
and AMerminal (NTA) fragments of proatrial natri-
uretic factor in 11 healthy subjects (O) and 10 
patients with cirrhosis ( • ) . 
8.2±0.9 fmol/ml). However, mean plasma 
concentrations of NTA were markedly 
(p<0.001) higher in cirrhosis than in controls 
(2334±291 fmol/ml vs 743±155 fmol/ml) (Fig. 
1). Renal function, as estimated by serum creati-
nine concentrations was no different in patients 
with cirrhosis when compared with healthy 
subjects (1.10±0.03 mg/100ml vs 1.03±0.05 
mg/100ml). 
D I S C U S S I O N 
The influence of posture on plasma concentra-
tions of C-terminal ANF has been the subject of 
some controversy, with some authors observing 
differences [9, 10] while others did not [11, 12]. 
In the present study, the concentration of the C -
terminal fragment was not influenced by the 
change from sitting to supine position. 
However, the change of posture initiated a 
significant increase of /V-terminal fragment 
concentrations. The decrease of heart rate as 
well as that of plasma renin activity in the 
supine position suggests a subtle increase of 
central vascular filling, which may be regarded 
as a stimulus of pro-ANF release. Thus, the 
likely augmentation of A N F release by the 
change of posture was reflected by the change 
of NTA concentrations, and not reflected by 
CTA determinations. 
Whereas many authors agree that CTA 
plasma levels are unchanged in cirrhosis [13], 
some report elevated levels (for review see 
[14]). In the present study, we found no differ-
ence in the plasma concentrations of CTA in 
patients with cirrhosis or healthy subjects. 
However, concentrations of the /V-terminal frag-
ment were elevated in cirrhosis by about three-
fold. This finding might be compatible with the 
contention of increased release of ANF in cir-
rhosis [15], but only in the presence of an 
enhanced clearance of C-terminal ANF. 
Since clearance of CTA seems unaltered in 
cirrhosis [16], this hypothesis is rather unlikely. 
Another explanation for increased NTA at nor-
mal CTA concentrations could be an impaired 
elimination of the /V-terminal fragment in cir-
rhosis. Renal elimination of NTA has been sug-
gested, based on the observation of more 
marked elevations of NTA than of CTA in 
patients with chronic renal failure [4]. In the cir-
rhotic patients of this study, normal serum crea-
tinine levels make significant renal impairment 
rather unlikely. However, in cirrhosis, renal 
blood flow can be reduced at unchanged serum 
creatinine concentrations; thus, the possibility 
cannot be excluded that the observed increase of 
NTA in cirrhosis could be partly caused by 
decreased renal elimination. Furthermore, influ-
ence of age cannot be excluded since patients 
and controls were not age-matched. However, 
the striking elevations of NTA observed in 
patients with cirrhosis suggest that the liver 
plays a role in the elimination of NTA from the 
circulation. 
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